St. Jude Medical’s revenue, earnings increase in first quarter

Tim Casey | | Cardiovascular Business | Economics

For the first quarter of fiscal year 2016, St. Jude Medical’s net sales increased 8 percent to $1.448 billion and its adjusted earnings increased 9 percent to $0.90 per share from the first quarter of last year.

Sales in atrial fibrillation increased 5 percent to $291 million, driven by the adoption of its FlexAbility and TactiCath ablation catheters. In the heart failure division, sales increased 49 percent to $374 million, led by increased adoption of the Heartmate II left ventricular assist system in the U.S. and the Heartmate 3 left ventricular assist system in Europe.

In October, St. Jude Medical acquired Thoratec for $3.3 billion. Thoratec manufactures the Heartmate II and 3 systems.

Sales in the neuromodulation division increased 8 percent to $116 million, while sales in the cardiovascular division were flat at $301 million.

Sales in the traditional cardiac rhythm management division declined 10 percent. The division includes implantable cardioverter defibrillators and pacemakers.

For the first quarter, net earnings were $95 million, or $0.33 per share, and adjusted net earnings were $259 million, or $0.90 per share.

St. Jude Medical said it expects revenue growth of 1-3 percent in the second quarter and 2-4 percent for the full year compared with the same time periods in 2015. The company also expects consolidated adjusted net earnings of $1.05 to $1.07 per share in the second quarter and $4.01 to $4.11 per share for the full year.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."